Open-Label Access Protocol of Denosumab for Subjects with Advanced Cancer

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-002114-36

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To facilitate the access of denosumab for subjects with advanced cancer who have participated in a denosumab phase 3 study until denosumab is approved and available for sale Safety Objective: To further assess the safety of denosumab for subjects who have participated in open label extensions of a denosumab advanced cancer phase 3 study


Critère d'inclusion

  • Bone Metastases in Subjects with Advanced Breast Cancer and Bone
  • Metastases in Men with Hormone-Refractory Prostate Cancer